Four Am Law 100 firms are facing off in a $2.2 billion takeover fight involving Endo International's bid to acquire Auxilium Pharmaceuticals, a deal that would stymie a $345 million tax inversion deal forged by the latter this summer with Canadian biotechnology firm QLT. Skadden, Arps, Slate, Meagher & Flom, which is currently advising Auxilium, has also done inversion work for Endo.
September 17, 2014 at 07:09 PM
1 minute read
Four Am Law 100 firms are facing off in a takeover fight involving Endo International’s unsolicited $2.2 billion cash-and-stock bid to buy Auxilium Pharmaceuticals.
The proposed transaction would scuttle Auxilium’s proposed $345 million acquisition earlier this summer of Canadian biotechnology firm QLT, a deal that would allow Auxilium to redomicile itself north of the border. On Wednesday, the Chesterbrook, Pa.-based Auxilium adopted a poison pill to fend off Endo.
Presented by BigVoodoo
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Duane Morris LLP seeks a highly motivated junior associate to join its dynamic and growing Labor and Employment Class Action group in Chicag...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Tired of the stress of the big city? Are you looking to improve your quality of life? Then consider practicing law at the Jersey Shore. Pe...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
The American Lawyer provides the most informed and trusted source of news, data, analysis and forecasting on the global business of law.
